Trial intelligence / Profile preview

rhM-tPA versus alteplase in acute ST-segment elevation myocardial infarction

CTR20132276Phase 2Completed

Sponsor
Beijing World Trade Dongrui Pharmaceutical Technology
Start
May 2014
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of reteplase in myocardial infarction (MI), sponsored by Beijing World Trade Dongrui Pharmaceutical Technology. Started May 2014; status: completed.

02

Drugs

reteplase
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on CTR20132276.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20132276.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call